Ketamine

Bexson Biomedical recently signed a deal with the Stevanato Group to develop a subcutaneous delivery system of ketamine. “SG EZ-be Pod,” a wearable device designed for administering subcutaneous drugs, would facilitate patient administration of medications outside of clinics...

Field Trip Health (NASDAQ: FTRP), a company offering mental health treatment using ketamine therapy, has inked a unique deal with Nue Life Health to expand its service offerings to at-home treatment. Field Trip currently has eleven clinics across North America, where the company provides...

The U.S. Patent and Trademark Office has granted Pharmather Holdings Ltd. (OTCQB: PHRRF) a patent for a ketamine production process. The patent, titled “Ketamine Flow Synthesis,” refers to a continuous-flow process technology for the preparation of ketamine and ketamine analogs. It...

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk, the tech tycoon soon-to-become media tycoon who smoked a joint on a live stream video with Joe Rogan opined on Twitter Inc (NYSE: TWTR) on the effectiveness of psychedelics and other plant-based substances as treatments for mental health-...

Bexson Biomedical, a private company in the psychedelics space, has inked a new agreement with Stevanato Group, an Italian-based provider of drug delivery solutions. Bexson is currently developing an improved version of ketamine called BB106, which allows for subcutaneous delivery of the drug. The...

Cory Jones of Healing Maps told Benzinga’s Javier Hasse at the inaugural Benzinga Psychedelics Capital Conference on Tuesday that research underway at such institutions as Johns Hopkins University and London’s Imperial College is "changing people’s minds...

NeonMind Biosciences Inc. (CSE:NEON) (OTCQB: NMDBF) (FRA:6UF) plans to launch 10 specialty mental health clinics over the next 3 years through alliances with SRx Health Solutions and BioScript Solutions, leading Canadian specialty healthcare services and medical treatment providers. "With very...

What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted...

The first study visit to measure the psychedelic effects of ketamine in the cerebral cortex blood flow is underway,  announced Cybin Inc. (NYSE: CYBN), which is sponsoring the research that will make heavy use of Kernel Flow, a quantitative neuroimaging technology. Without...

This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming...

Meet the person behind Irwin Naturals Inc. (CSE:IWIN) (OTC: IWINF), an herbal supplement formulator and leader in the nutrition industry at the forefront of the "psychedelics renaissance." Klee Irwin serves as CEO and chairman of Irwin Naturals and director of Quantum Gravity...

This article by Veronica Castillo was originally published on Microdose and appears here with permission. What is Ketamine Ketamine is a compound that comes from Pochonia Chlamydosporia, also known as p. Chlamydosporia. Pochonia Chlamydosporia is a fungus that grows on the roots of...

Mental health company specialized in psychedelic medicine Novamind Inc. (CSE:NM) (OTCQB: NVMDF) (FSE:HN2) has been selected by the Ketamine Research Foundation to host a phase II clinical trial investigating ketamine-assisted psychotherapy (KAP) for adults with life-threatening illness. The FDA...

PharmaTher, a Toronto-based biotechnology company focused on discovering and developing drugs using Ketamine, received an Orphan Drug Designation (ODD) for a ketamine-based medicine to treat a rare seizure condition.  Status Epilepticus is characterized by a seizure lasting more than five...

This article was originally published on Psychedelic Spotlight and appears here with permission. Research will focus on how various psychedelics can be used under proper supervision and guidance to treat severe depression, anxiety and PTSD. Is Texas poised to become a hub for psychedelic research?...